Effects of a Peer-facilitated, Acceptance-based Self-learning for Illness Management (PASIM) Program
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-64
SponsorChinese University of Hong Kong
About this trial
Psychosis is a very disabling mental illness with a wide range of dysregulations and disruptions in cognition, emotions, and behaviors, resulting in poor functioning and frequent relapses, especially in the first five years of the illness. There is a knowledge gap about whether Peer-facilitated, Acceptance-based Self-learning for Illness Management (PASIM) can have longer-term and more significant benefits than current professional-led psychoeducation in diverse health outcomes of these psychotic patients such as functioning, problem-solving, and recovery. This multi-center randomized controlled trial with repeated measures, 3-arm design is proposed to test and compare the effects between two alternative interventions (PASIM and Psychoeducation Group program) and a usual-care-only group over an 18-month follow-up.
Eligibility criteria
Qualifiers
Primarily diagnosed with psychosis (or ROP with <5 years of illness as defined in recent literature), including brief, first-episode and other psychotic disorders according to the criteria of the DSM-5 [American Psychiatric Association 2013];
H.K. Chinese residents, aged 18-64 years;
Global Assessment of Functioning scores ≥51, indicating mild to moderate symptoms and difficulties in psychosocial/occupational functioning [American Psychiatric Association 2013], being mentally stable to comprehend APSI or psychoeducation and outcome measures;
Able to read and understand Cantonese/ Mandarin.
Disqualifiers
Have received or are receiving other psychotherapies;
Comorbidity with other mental (learning disability, cognitive, or personality disorder) or significant medical disease(s);
And/or communication, visual or hearing difficulty.
Trial design
Treatments tested in this trial
- PASIM program
- Psychoeducation
- Usual-Care-only
Treatment groups
186 Participants
are divided into 3 treatment groupsSponsors and collaborators
Chinese University of Hong Kong
Lead sponsor
Integrated Community Centers for Mental Wellness
Collaborator
Psychiatric outpatient clinics
Collaborator
Source ClinicalTrials.gov